Genfit S.A.

OVERVALUEDGNFT · NASDAQ · Healthcare
GNFT·NASDAQ·Healthcare
OVERVALUED
Genfit S.A.
25.1%downside
MARKET PRICE
$7.82
FAIR PRICE
$5.86
MARGIN
$1.96
UNDERVALUEDFAIROVERVALUED
P/E RATIO
N/A
DIV. YIELD
N/A
ROE
8.5%
MARKET CAP
$328M
FPI
fairpriceindex.com

FAIR PRICE VALUATION

25.1%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$7.82

FAIR PRICE

$5.86

MARGIN

$1.96

UNDERVALUEDFAIROVERVALUED

P/E Ratio

N/A

Div. Yield

N/A

ROE

8.5%

Average

Market Cap

$328M

Small-cap

NOW AVAILABLE

Get notified when GNFT's fair price changes

Push notifications when GNFT's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

1.6/ 10

Challenges include volatile earnings pattern and below-average fundamental quality.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$4.69CONSERVATIVE ENTRY
$5.86FAIR PRICE
$7.82MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$4.69

Fair price × 0.80

DISTANCE

40.1%

Price to entry level

At the current price of $7.82, GNFT trades 40.1% above the conservative entry level of $4.69. This entry level represents a 20% margin of safety below the calculated fair price of $5.86 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate GNFT's fair price

Genfit S.A.'s fair price of $5.86 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $7.82, GNFT trades 25.1% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting GNFT's risk profile.

RELATIVE · 30%

Comparing GNFT's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for GNFT, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate GNFT's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for GNFT.

Explore on Bulios

FAQ

What is the fair price of GNFT?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Genfit S.A. is $5.86. At the current market price of $7.82, GNFT trades 25.1% above its calculated fair value.

Is GNFT overvalued or undervalued?+

Genfit S.A. is currently overvalued based on our valuation model. The stock trades at $7.82, which is 25.1% above the fair price of $5.86.

What is the margin of safety for GNFT?+

With a 20% margin of safety applied to the fair price of $5.86, the conservative entry level for GNFT is $4.69. At the current market price of $7.82, the stock trades 40.1% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is GNFT's fair price updated?+

We update fair price calculations for GNFT daily after market close. The current fair price of $5.86 incorporates the latest market data and sector multiples.

What factors affect GNFT's fair price calculation?+

GNFT's fair price of $5.86 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 8.5%.

Is GNFT a good buy right now?+

At $7.82, GNFT trades 25.1% above our fair value estimate of $5.86. The stock is currently overvalued. ROE stands at 8.5% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does GNFT pay dividends?+

GNFT does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.